SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TTPH, Tetraphase Pharmaceuticals
TTPH 2.200-3.5%Jul 28 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
HardToFind
To: HardToFind who wrote (50)8/3/2017 9:26:33 PM
From: scaram(o)uche1 Recommendation  Read Replies (1) of 80
 
SEC has caught lotsa folk violating that provision, you're correct that it does happen.

But any fund manager that risks doing such is INSANE.

You want an issued press release? From yesterday's quarterly.....

Second Quarter and Recent Highlights

  • Announced positive top-line results from IGNITE4, the Company's phase 3 clinical trial evaluating the efficacy and safety of twice-daily intravenous (IV) eravacycline compared to meropenem for the treatment of patients with complicated intra-abdominal infections (cIAI). The results of IGNITE4, which enrolled 500 patients, demonstrated statistical non-inferiority of eravacycline to meropenem for the primary efficacy endpoint of clinical response at the test-of-cure (TOC) visit.
  • Presented data at ASM Microbe 2017 including additional supportive data generated for eravacycline demonstrating consistent potency against drug-resistant bacteria in ongoing global surveillance studies and positive data from phase 1 single-ascending dose studies for its two pipeline programs, TP-6076 and TP-271.
  • Successfully completed a public offering of 10,000,000 shares of common stock with gross proceeds totaling $65 million.
    • Report TOU ViolationShare This Post
     Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

    HomeMailHotSubjectMarksPeopleMarksKeepersSettings
    Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
    © 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News